STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
STSA
Delisted
STSA was delisted on the 7th of June, 2023.
48 hedge funds and large institutions have $49.5M invested in Satsuma Pharmaceuticals, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 13 increasing their positions, 15 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
48
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.44M | |
| 2 | +$902K | |
| 3 | +$413K | |
| 4 |
Russell Investments Group
London,
United Kingdom
|
+$359K |
| 5 |
PP
PDT Partners
New York
|
+$235K |
Top Sellers
| 1 | -$859K | |
| 2 | -$485K | |
| 3 | -$331K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$176K |
| 5 |
B
Bailard
Foster City,
California
|
-$150K |